Eli Lilly CEO on Trump, obesity drugs, and a guidance miss
In a live taping of “The Readout LOUD” at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare’s drug price negotiation, and obesity drugs.
In a live taping of “The Readout LOUD” at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare’s drug price negotiation, and obesity drugs.
This cross-sectional study identifies variables in cardiac biomarker testing and their association with acute coronary syndrome incidence among adults visiting the emergency department.
This cross-sectional study uses data from the All of Us Research Program to investigate whether sexual and gender minority (SGM) populations have a higher prevalence…
Introduction Faced with a backdrop of an increasing chronic disease burden from an ageing global population compounded with rising healthcare costs, health systems are required…
The poor management of public health risks associated with travel by most countries proved among the most contentious issue areas during the COVID-19 pandemic. Evidence…
Introduction National malaria programmes must weigh the relative benefits of different vector control and elimination tools to prioritise resource allocation with the greatest impact. This…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Another busy
DHEA is a supplement that some people take to fight the effects of aging. But does it work? And is it safe?…
Reeco, a startup that has developed an AI-driven procure-to-pay platform for the hospitality industry, announced today it has secured $15
The stem cells in your bone marrow may be small, but they can save a life. Here’s how.
Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit sales gains in a trio of its branded drugs…